Inventor

Dahlia WEISS

Inventor
US

Overview

11→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 11 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes21%
C12NMicroorganisms or enzymes12%
A61NElectrotherapy7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to NURIX THERAPEUTICS INC (11)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to GILEAD SCIENCES INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NURIX THERAPEUTICS INC112022–2026
GILEAD SCIENCES INC12026
Locations
LocationPatentsSpan
US112022–2026